European Patent Office To Issue Patent To Phyton Biotech Covering Methods Of Making T

[News]

Phyton Biotech GmbH, a world leader in plant cell culture technology, reports that the European Patent Office has announced its intention to grant a European patent to Phyton covering methods of producing taxanes such as paclitaxel. Paclitaxel, the active ingredient in Bristol-Myers Squibb's TAXOL®, is useful in the treatment of breast, ovarian, lung, and other forms of cancer.

More... (http://www.medicalnewstoday.com/articles/167200.php)